Your browser doesn't support javascript.
loading
Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng, Xiangdong; Wu, Dan; Xu, Nong; Chen, Luchuan; Yan, Zhilong; Chen, Ping; Zhou, Lei; Yu, Jianfa; Cui, Jiuwei; Li, Wei; Wang, Chang; Feng, Wenming; Wei, Yunhai; Yu, Pengfei; Du, Yian; Ying, Jieer; Xu, Zhiyuan; Yang, Litao; Zhang, Yunli.
Affiliation
  • Cheng X; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China. abdsurg@163.com.
  • Wu D; Department of General Surgery, Second Affiliated Hospital of Medical College of Zhejiang University, Zhejiang, China.
  • Xu N; Department of Oncology, First Affiliated Hospital of Medical College of Zhejiang University, Zhejiang, China.
  • Chen L; Department of Gastrointestinal Oncology Surgery, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China.
  • Yan Z; Department of Gastrointestinal Surgery, Ningbo First Hospital, Zhejiang, China.
  • Chen P; Department of Gastrointestinal Surgery, Ningbo Second Hospital, Zhejiang, China.
  • Zhou L; Department of General Surgery, China-Japan Friendship Hospital, Beijing, China.
  • Yu J; Department of Gastrointestinal Surgery, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Zhejiang, China.
  • Cui J; Oncology Central, First Hospital of Jilin University, Jilin, China.
  • Li W; Oncology Central, First Hospital of Jilin University, Jilin, China.
  • Wang C; Oncology Central, First Hospital of Jilin University, Jilin, China.
  • Feng W; Department of Hepatobiliary Pancreatic Surgery, Huzhou First People's Hospital, Zhejiang, China.
  • Wei Y; Department of Hepatobiliary Pancreatic Surgery, Huzhou Central Hospital (Zhejiang University Huzhou Hospital), Zhejiang, China.
  • Yu P; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China.
  • Du Y; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China.
  • Ying J; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China.
  • Xu Z; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China.
  • Yang L; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China.
  • Zhang Y; Department of Abdominal Surgery, Zhejiang Cancer Hospital (University of Chinese Academy of Sciences Cancer Hospital), Zhejiang, China.
BMC Cancer ; 21(1): 56, 2021 Jan 12.
Article in En | MEDLINE | ID: mdl-33435909
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Chemotherapy, Adjuvant / Gastrectomy Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Chemotherapy, Adjuvant / Gastrectomy Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: China